Rodent faeces and damaged equipment land Chinese OTC maker FDA warning
The US FDA has published a warning letter slamming the sanitary conditions of a Chinese OTC facility run by Bicooya Cosmetics Limited.
The US FDA has published a warning letter slamming the sanitary conditions of a Chinese OTC facility run by Bicooya Cosmetics Limited.
Spray drying and capsule filling-focused Micro-Sphere is expanding manufacturing capabilities at its facility in Ticino, Switzerland.
Q&A
Clinerion recently filed a patent for its “anonymized identification” (ANID) technology, the use of which avoids possible privacy concerns associated with electronic patient data, says CEO.
The FDA and EMA have reached a new milestone during the process to implement mutual recognition of drug manufacturing facility inspections.
The US Food and Drug Administration (FDA) has released a document to address the integration of pharmaceutical facility evaluations and inspections.